alexa
Reach Us +441414719275
Editor - Venkateswarlu Chamcha | University of Louisiana | 19887
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Venkateswarlu Chamcha

Venkateswarlu Chamcha
Venkateswarlu Chamcha
University  of Louisiana
USA

Biography

Dr. Venkateswarlu Chamcha trained as molecular virologist at National Institute of Virology, India and received a PhD degree for developing a vaccine for Chandipura viral encephalitis disease in 2010. He has very good knowledge in developing vaccines for various viral diseases and testing or conducting various vaccine trials in animal models such as Mice, Rabbits, Guinea pigs and in Rhesus macaques. Being a postdoctoral fellow at Emory University's Yerkes National Primate Research Center since 2010, he is working extensively on HIV vaccine development by using a probiotics organism i.e. lactococcus lactis. This vaccine modality is one of the novel approaches and gave very interesting results and Dr. Chamcha is one of the key people in developing this project. His studies in mice and Nonhuman primates demonstrated that a recombinant L.lactis generates good vaccine specific immune responses targeted mainly in the gut of these animals. Other aspects of his studies involved are conducting some efficacy studies using DNA prime and MVA boost vaccine modalities and understanding the immune correlates of these vaccine mediated immunity and protection to SIV infection. Currently these vaccine modalities have been tested in human clinical trials for HIV vaccine in USA.

Research Interest

HIV/SIV vaccine development, Understanding the mucosal immunity to Vaccines, Developing probiotic bacteria as a vaccine vector for viral diseases, Modulating the immune responses in the GALT to HIV vaccines

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Current Scenario and Future Prospects of HIV Vaccines

Advancements of HIV/AIDS Treatment, Socio-Economic Impact, and the Impact of the HIV Co-infections

Venkateswarlu Chamcha
Editor Note: J AIDS Clin Res 2016, 7: e125
DOI: 10.4172/2155-6113.1000e125

Editor Note

Venkateswarlu Chamcha
Editor Note: J AIDS Clin Res 2016, 7: e124
DOI: 10.4172/2155-6113.1000e124

Probiotics Based Approaches to Target Mucosal Compartments: Potential Novel Approaches to HIV Vaccine Development

Venkateswarlu Chamcha
Editor Note: J AIDS Clin Res 2016, 7: e120
DOI: 10.4172/2155-6113.1000e120
Venkateswarlu Chamcha
Editorial: J AIDS Clin Res 2016, 7: e119
DOI: 10.4172/2155-6113.1000e119
Top